(Q33977729)

English

Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Activities of new antimicrobial agents (trovafloxacin, moxifloxacin, sanfetrinem, and quinupristin-dalfopristin) against Bacteroides fragilis group: comparison with the activities of 14 other agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

Bacteroides fragilis

object named as

Bacteroides fragilis

1 reference

based on heuristic

inferred from title

author name string

C Betriu

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M Gómez

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M L Palau

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A Sánchez

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J J Picazo

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 September 1999

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2320-2322

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Interactions of beta-lactamases with sanfetrinem (GV 104326) compared to those with imipenem and with oral beta-lactams.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

5 July 2018

In vitro activities of cefminox against anaerobic bacteria compared with those of nine other compounds

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

5 July 2018

In vitro and in vivo antibacterial activities of GV129606, a new broad-spectrum trinem

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

5 July 2018

Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

5 July 2018

Analysis of trends in antimicrobial resistance patterns among clinical isolates of Bacteroides fragilis group species from 1990 to 1994.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

5 July 2018

In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

5 July 2018

Longitudinal study of susceptibilities of species of the Bacteroides fragilis group to five antimicrobial agents in three medical centers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

5 July 2018

Resistance of anaerobic bacteria to antimicrobial agents in Spain

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

5 July 2018

In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

29 October 2018

Susceptibility patterns and resistance to imipenem in the Bacteroides fragilis group species in Japan: a 4-year study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

29 October 2018

A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in the United States.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=89472

29 October 2018

Comparative in vitro activity of BAY 12-8039 and five other antimicrobial agents against anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/10471590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bay 12-8039, a new 8-methoxy-quinolone: comparative in-vitro activity with nine other antimicrobials against anaerobic bacteria

1 reference

https://pubmed.ncbi.nlm.nih.gov/10471590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antimicrobial resistance in anaerobic bacteria: current situation

1 reference

https://pubmed.ncbi.nlm.nih.gov/10471590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989

1 reference

https://pubmed.ncbi.nlm.nih.gov/10471590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam

1 reference

https://pubmed.ncbi.nlm.nih.gov/10471590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Susceptibility of anaerobic bacteria to the new streptogramin RP 59500 in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/10471590

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.43.9.2320

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33977729&oldid=1630124207"